3-Selenocyanatopropyl 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate

ID: ALA4875617

PubChem CID: 164626525

Max Phase: Preclinical

Molecular Formula: C21H26N2O3Se

Molecular Weight: 433.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)OCCC[Se]C#N)OCC3

Standard InChI:  InChI=1S/C21H26N2O3Se/c1-3-15-7-5-8-16-17-9-11-26-21(4-2,20(17)23-19(15)16)13-18(24)25-10-6-12-27-14-22/h5,7-8,23H,3-4,6,9-13H2,1-2H3

Standard InChI Key:  ZNNJSDKTICYYLQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   16.6699  -14.7755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3798  -15.1841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3787  -14.3650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6949  -15.6275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7353  -16.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4617  -16.8152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1100  -15.5526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1502  -16.3679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8729  -15.2626    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3847  -15.8985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9352  -16.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3001  -17.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1142  -17.3546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5621  -16.6691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1947  -15.9444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6419  -15.2604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4578  -15.3058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0916  -13.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8034  -14.3669    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0916  -13.1370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5153  -13.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2271  -14.3669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9348  -13.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6466  -14.3669    0.0000 Se  0  0  0  0  0  2  0  0  0  0  0  0
   22.3585  -13.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0668  -13.5423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6688  -13.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  2  4  1  0
  2  7  1  0
  4  5  1  0
  5  6  1  0
  6  8  1  0
  7  8  2  0
  8 11  1  0
 10  9  1  0
  9  7  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
  3 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  3  0
  1 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4875617

    ---

Associated Targets(Human)

Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BGC-823 (3035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.41Molecular Weight (Monoisotopic): 434.1109AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. He X, Nie Y, Zhong M, Li S, Li X, Guo Y, Liu Z, Gao Y, Ding F, Wen D, Zhang Y..  (2021)  New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.,  218  [PMID:33799070] [10.1016/j.ejmech.2021.113384]

Source